OTCMKTS:EPGNY

Epigenomics Stock Forecast, Price & News

$33.00

0.00 (0.00 %)

(As of 01/15/2021 12:00 AM ET)

Add

Compare

Today's Range

$33.00

Now: $33.00▼

$33.00

50-Day Range

$2.66

MA: $17.71▼

$33.00

52-Week Range

$2.42

Now: $33.00▼

$19.90

VolumeN/A

Average Volume1,054 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA and, HCCBloodTest, a blood test for cirrhotic patients at high-risk for the development of hepatocellular carcinoma (HCC) The comapny was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo Gut on April 30, 1997 and is headquartered in Berlin, Germany.

Overall MarketRank^™

0.56 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Epigenomics.

2.8 Community Rank

Outperform Votes
Epigenomics has received 48 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Epigenomics has received 37 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Epigenomics has received 56.47% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Epigenomics and other stocks. Vote “Outperform” if you believe EPGNY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EPGNY will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Epigenomics does not currently pay a dividend.
Dividend Growth
Epigenomics does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Epigenomics insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Diagnostics & Research

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:EPGNY

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.epigenomics.com

Phone(493) 024-3450

Employees38

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

$33.00

0.00 (0.00 %)

(As of 01/15/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive EPGNY News and Ratings via Email

Sign-up to receive the latest news and ratings for EPGNY and its competitors with MarketBeat's FREE daily newsletter.

Epigenomics (OTCMKTS:EPGNY) Frequently Asked Questions

How has Epigenomics' stock been impacted by Coronavirus?

Epigenomics' stock was trading at $7.55 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, EPGNY shares have increased by 337.1% and is now trading at $33.00.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Epigenomics?

Wall Street analysts have given Epigenomics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Epigenomics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Epigenomics?

Epigenomics saw a decrease in short interest during the month of December. As of December 31st, there was short interest totaling 400 shares, a decrease of 76.5% from the December 15th total of 1,700 shares. Based on an average trading volume of 500 shares, the days-to-cover ratio is presently 0.8 days.
View Epigenomics' Short Interest.

Who are some of Epigenomics' key competitors?

Some companies that are related to Epigenomics include (BUX) (BUX), 12144 (IME), BARD1 Life Sciences Limited (BD1.AX) (BD1), Charles River Laboratories International (CRL), Cryosite Limited (CTE.AX) (CTE), dorsaVi Ltd (DVL.AX) (DVL), Eternity Healthcare (ETAH), Genetic Signatures Limited (GSS.AX) (GSS), Genetic Technologies Limited (GTG.AX) (GTG), Imagion Biosystems Limited (IBX.AX) (IBX), Integral Diagnostics Limited (IDX.AX) (IDX), Lifespot Health Ltd (LSH.AX) (LSH), Medical Imaging (MEDD), OncoSil Medical Limited (OSL.AX) (OSL) and Parallax Health Sciences (PRLX).
View all of EPGNY's competitors.

Who are Epigenomics' key executives?

Epigenomics' management team includes the following people:

Gregory K. Hamilton, Chief Executive Officer
Jorge A. Garces, President & Chief Scientific Officer
Albert Weber, Executive Vice President-Finance
Frederic Hilke, Media & Investor Relations Contact
Annett Dietrich, Manager-Human Resources

What is Epigenomics' stock symbol?

Epigenomics trades on the OTCMKTS under the ticker symbol "EPGNY."

How do I buy shares of Epigenomics?

Shares of EPGNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Epigenomics' stock price today?

One share of EPGNY stock can currently be purchased for approximately $33.00.

What is Epigenomics' official website?

The official website for Epigenomics is www.epigenomics.com.

How can I contact Epigenomics?

The company can be reached via phone at (493) 024-3450.

This page was last updated on 1/19/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Epigenomics Stock Forecast, Price & News

Adding

Adding

Adding Epigenomics AG

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

2.8 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth

0.0 Company Ownership

Insider Buying vs. Insider Selling

0.0 Earnings and Valuation

Industry, Sector and Symbol

Debt

Price-To-Earnings

Sales & Book Value

Profitability

Miscellaneous

Receive EPGNY News and Ratings via Email

Epigenomics (OTCMKTS:EPGNY) Frequently Asked Questions

How has Epigenomics' stock been impacted by Coronavirus?

What stocks does MarketBeat like better than Epigenomics?

Are investors shorting Epigenomics?

Who are some of Epigenomics' key competitors?

Who are Epigenomics' key executives?

What is Epigenomics' stock symbol?

How do I buy shares of Epigenomics?

What is Epigenomics' stock price today?

What is Epigenomics' official website?

How can I contact Epigenomics?

30 Days of MarketBeat All Access for $1.00

MarketRank^™

Overall MarketRank^™